- Home
- Publications
- Publication Search
- Publication Details
Title
What Is New about New Antidepressants?
Authors
Keywords
-
Journal
PSYCHOTHERAPY AND PSYCHOSOMATICS
Volume 87, Issue 3, Pages 129-139
Publisher
S. Karger AG
Online
2018-05-23
DOI
10.1159/000488945
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial
- (2018) Michael F. Grunebaum et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine: Quo Vadis?
- (2018) Charles B. Nemeroff AMERICAN JOURNAL OF PSYCHIATRY
- Combined Analysis of Mifepristone for Psychotic Depression: Plasma Levels Associated With Clinical Response
- (2018) Thaddeus S. Block et al. BIOLOGICAL PSYCHIATRY
- Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration
- (2018) Jennifer W. Evans et al. BIOLOGICAL PSYCHIATRY
- More data, more answers: picking the optimal antidepressant
- (2018) Sagar V Parikh et al. LANCET
- Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
- (2018) Andrea Cipriani et al. LANCET
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
- (2018) Ella J. Daly et al. JAMA Psychiatry
- Administration of ketamine for unipolar and bipolar depression
- (2017) Christoph Kraus et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment
- (2017) Somaia Mohamed et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Predictors of remission from generalized anxiety disorder and major depressive disorder
- (2017) Kristen M. Kelly et al. JOURNAL OF AFFECTIVE DISORDERS
- Treatment of neurocognitive symptoms in unipolar depression: A systematic review and future perspectives
- (2017) E. Salagre et al. JOURNAL OF AFFECTIVE DISORDERS
- Empirically supported psychological treatments and the Research Domain Criteria (RDoC)
- (2017) Dean McKay et al. JOURNAL OF AFFECTIVE DISORDERS
- Dextromethorphan/quinidine pharmacotherapy in patients with treatment resistant depression: A proof of concept clinical trial
- (2017) James W. Murrough et al. JOURNAL OF AFFECTIVE DISORDERS
- Brain-derived neurotrophic factor in mood disorders and antidepressant treatments
- (2017) Eero Castrén et al. NEUROBIOLOGY OF DISEASE
- Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies
- (2017) Christopher E.M. Griffiths et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Cognitive Behavior Therapy May Sustain Antidepressant Effects of Intravenous Ketamine in Treatment-Resistant Depression
- (2017) Samuel T. Wilkinson et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Experimental medication treatment approaches for depression
- (2017) D F Ionescu et al. Translational Psychiatry
- Efficacy of antidepressants: bias in randomized clinical trials and related issues
- (2017) Sheng-Min Wang et al. Expert Review of Clinical Pharmacology
- Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
- (2016) Jaskaran B. Singh et al. BIOLOGICAL PSYCHIATRY
- Ketamine abuse potential and use disorder
- (2016) Yu Liu et al. BRAIN RESEARCH BULLETIN
- Vortioxetine versus Duloxetine in the Treatment of Patients with Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials
- (2016) Guangjian Li et al. CLINICAL DRUG INVESTIGATION
- Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine
- (2016) Eric Wohleb et al. Current Neuropharmacology
- Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials
- (2016) William A. Carlezon et al. DEPRESSION AND ANXIETY
- WHITHER KETAMINE AS AN ANTIDEPRESSANT: PANACEA OR TOXIN?
- (2016) D. Jeffrey Newport et al. DEPRESSION AND ANXIETY
- KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE
- (2016) William V. Bobo et al. DEPRESSION AND ANXIETY
- The role of GSK-3 in treatment-resistant depression and links with the pharmacological effects of lithium and ketamine: A review of the literature
- (2016) J.F. Costemale-Lacoste et al. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE
- Antidepressant effects of TBE-31 and MCE-1, the novel Nrf2 activators, in an inflammation model of depression
- (2016) Wei Yao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Compulsivity—A new trans-diagnostic research domain for the Roadmap for Mental Health Research in Europe (ROAMER) and Research Domain Criteria (RDoC) initiatives
- (2016) N.A. Fineberg et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Ketamine modulates catecholamine transmission in the bed nucleus of stria terminalis: The possible role of this region in the antidepressant effects of ketamine
- (2016) Roberto Cadeddu et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Fronto-limbic effective connectivity as possible predictor of antidepressant response to SSRI administration
- (2016) Benedetta Vai et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The rapid antidepressant and anxiolytic-like effects of YY-21 involve enhancement of excitatory synaptic transmission via activation of mTOR signaling in the mPFC
- (2016) Fei Guo et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults
- (2016) Michael E. Thase et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Treatment outcome variation between depression symptom combinations in the STAR*D study
- (2016) Charles M. Olbert et al. JOURNAL OF AFFECTIVE DISORDERS
- Riluzole combination therapy for moderate-to-severe major depressive disorder: A randomized, double-blind, placebo-controlled trial
- (2016) Elaheh Salardini et al. JOURNAL OF PSYCHIATRIC RESEARCH
- The unfulfilled promise of the antidepressant medications
- (2016) Christopher G Davey et al. MEDICAL JOURNAL OF AUSTRALIA
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors
- (2016) Edgardo Falcon et al. NEUROPSYCHOPHARMACOLOGY
- The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
- (2016) André F. Carvalho et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Predictors of discontinuation of antipsychotic medication and subsequent outcomes in the European First Episode Schizophrenia Trial (EUFEST)
- (2016) Karin Landolt et al. SCHIZOPHRENIA RESEARCH
- Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant
- (2016) Weili Zhu et al. Neuroscience Bulletin
- Heterogeneity in 10-Year Course Trajectories of Moderate to Severe Major Depressive Disorder
- (2016) Katherine L. Musliner et al. JAMA Psychiatry
- Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake Inhibitor
- (2016) Fangxi Zhang et al. Scientific Reports
- Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
- (2015) D. Jeffrey Newport et al. AMERICAN JOURNAL OF PSYCHIATRY
- The many different faces of major depression: It is time for personalized medicine
- (2015) S. Mechiel Korte et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A New Empirical Definition of Major Depressive Episode Recovery and Its Positive Impact on Future Course of Illness
- (2015) Lewis L. Judd et al. JOURNAL OF CLINICAL PSYCHIATRY
- Treatment escalation in patients not responding to pharmacotherapy, psychotherapy, and electro-convulsive therapy: experiences from a novel regimen using intravenous S-ketamine as add-on therapy in treatment-resistant depression
- (2015) Bernd Kallmünzer et al. JOURNAL OF NEURAL TRANSMISSION
- Neural Correlates of Three Promising Endophenotypes of Depression: Evidence from the EMBARC Study
- (2015) Christian A Webb et al. NEUROPSYCHOPHARMACOLOGY
- The VA augmentation and switching treatments for improving depression outcomes (VAST-D) study: Rationale and design considerations
- (2015) Somaia Mohamed et al. PSYCHIATRY RESEARCH
- Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials
- (2014) Stuart A. Montgomery et al. CNS SPECTRUMS
- Pharmacokinetic evaluation of vortioxetine for the treatment of major depressive disorder
- (2014) Steven L Dubovsky Expert Opinion on Drug Metabolism & Toxicology
- Combined treatment with atypical antipsychotics and antidepressants in treatment-resistant depression: preclinical and clinical efficacy
- (2014) Zofia Rogóż Pharmacological Reports
- Rational Use of Antidepressant Drugs
- (2014) Giovanni A. Fava PSYCHOTHERAPY AND PSYCHOSOMATICS
- Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder
- (2013) Gerald Gartlehner et al. ANNALS OF INTERNAL MEDICINE
- 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension
- (2013) Giuseppe Mancia et al. BLOOD PRESSURE
- Talking to the Synapse: How Antidepressants Can Target Glial Cells to Reshape Brain Circuits
- (2013) Barbara Benedetto et al. CURRENT DRUG TARGETS
- Vilazodone lacks proarrhythmogenic potential in healthy participants: a thorough ECG study
- (2013) John Edwards et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Clinical Practice Guidelines for the Management of Hypertension in the Community A Statement by the American Society of Hypertension and the International Society of Hypertension
- (2013) Michael A. Weber et al. JOURNAL OF HYPERTENSION
- Antidepressants Normalize the Default Mode Network in Patients With Dysthymia
- (2013) Jonathan Posner et al. JAMA Psychiatry
- Benefits From Antidepressants
- (2012) Robert D. Gibbons et al. ARCHIVES OF GENERAL PSYCHIATRY
- The Roles of Neurotrophic Factor and Wnt Signaling in Depression
- (2011) B Voleti et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Epigenetic Code in Depression: Implications for Treatment
- (2011) M Schroeder et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- 5-HT2B receptors are required for serotonin-selective antidepressant actions
- (2011) S L Diaz et al. MOLECULAR PSYCHIATRY
- Raphe-mediated signals control the hippocampal response to SRI antidepressants via miR-16
- (2011) J M Launay et al. Translational Psychiatry
- Remission in depressed outpatients: More than just symptom resolution?
- (2007) Mark Zimmerman et al. JOURNAL OF PSYCHIATRIC RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started